Maija Anderson

Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial

Beatriz Grinsztejn, Mina C. Hosseinipour, Heather J. Ribaudo et al. · The Lancet Infectious Diseases · 2014 · 511 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +9

A Phase 2b Study to Evaluate the Safety and Efficacy of VRC01 Broadly Neutralizing Monoclonal Antibody in Reducing Acquisition of HIV-1 Infection in Women in Sub-Saharan Africa: Baseline Findings

Nyaradzo Mgodi, Simbarashe Takuva, Srilatha Edupuganti et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2021 · 45 citations · Full text

Public Health, Community Health, Immunology +17

Feasibility and Successful Enrollment in a Proof-of-Concept HIV Prevention Trial of VRC01, a Broadly Neutralizing HIV-1 Monoclonal Antibody

Srilatha Edupuganti, Nyaradzo Mgodi, Shelly Karuna et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2021 · 26 citations · Full text

Public Health, Immunology, Pharmacotherapy +17

Vaccination with mRNA-encoded membrane-anchored HIV envelope trimers elicited tier 2 neutralizing antibodies in a phase 1 clinical trial

K. Rachael Parks, Zoe Moodie, Mary Allen et al. · Science Translational Medicine · 2025 · 26 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

Value of colposcopy in sexually transmitted diseases clinic based on first year's experience.

Micheline Byrne, David Taylor‐Robinson, Maija Anderson et al. · Sexually Transmitted Infections · 1989 · 17 citations · Full text

Medicine, Gynecology, Pathology +15